Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about TFF Pharmaceuticals aggregated by PharmaCompass.com.

    Client Virtual Booth

    TFF PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    TFF Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2801 Via Fortuna, Suite 425,Austin, Texas 78746
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://tffpharma.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    TFF: More Positive Tacrolimus Inhalation Phase 2 Data
    TFF: More Positive Tacrolimus Inhalation Phase 2 Data

    https://www.globenewswire.com/news-release/2024/04/15/2862639/0/en/TFF-Pharmaceuticals-Announces-Additional-Positive-Data-from-the-Tacrolimus-Inhalation-Powder-TFF-TAC-Phase-2-Trial-Following-Oral-Presentation-at-the-ISHLT-44th-Annual-Late-Breakin.html

    GLOBENEWSWIRE
    15 Apr 2024
    Share Share
    TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
    TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com/news-release/2024/03/28/2854458/0/en/TFF-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html

    GLOBENEWSWIRE
    28 Mar 2024
    Share Share
    TFF Pharmaceuticals Announces Updated Data from the TFF TAC & TFF VORI Programs
    TFF Pharmaceuticals Announces Updated Data from the TFF TAC & TFF VORI Programs

    https://www.globenewswire.com/news-release/2024/03/27/2853586/0/en/TFF-Pharmaceuticals-Announces-Updated-Data-from-the-Tacrolimus-Inhalation-Powder-TFF-TAC-and-Voriconazole-Inhalation-Powder-TFF-VORI-Clinical-Programs.html

    GLOBENEWSWIRE
    27 Mar 2024
    Share Share
    TFF Announces Oral Presentation Phase 2 Study of Tacrolimus Inhalation Powder
    TFF Announces Oral Presentation Phase 2 Study of Tacrolimus Inhalation Powder

    https://www.globenewswire.com/news-release/2024/03/25/2851685/0/en/TFF-Pharmaceuticals-Announces-Oral-Presentation-of-Interim-Data-from-the-Phase-2-Study-of-Tacrolimus-Inhalation-Powder-TFF-TAC-for-the-Prevention-of-Lung-Transplant-Rejection-at-th.html

    GLOBENEWSWIRE
    25 Mar 2024
    Share Share
    TFF Pharma Announces Closing of $1.2 Million Registered Direct Offering Priced
    TFF Pharma Announces Closing of $1.2 Million Registered Direct Offering Priced

    https://www.globenewswire.com/news-release/2024/03/22/2851119/0/en/TFF-Pharmaceuticals-Announces-Closing-of-1-2-Million-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    22 Mar 2024
    Share Share
    TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering
    TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering

    https://www.globenewswire.com/news-release/2024/03/20/2849594/0/en/TFF-Pharmaceuticals-Announces-1-2-Million-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    20 Mar 2024
    Share Share
    TFF Pharmaceuticals Announces Update on Clinical Programs
    TFF Pharmaceuticals Announces Update on Clinical Programs

    https://www.globenewswire.com/news-release/2024/03/20/2849420/0/en/TFF-Pharmaceuticals-Announces-Update-on-Clinical-Programs.html

    GLOBENEWSWIRE
    20 Mar 2024
    Share Share
    TFF Pharma to Participate in the 36th Annual Roth Conference “ March 17-19, 2024
    TFF Pharma to Participate in the 36th Annual Roth Conference “ March 17-19, 2024

    https://www.globenewswire.com//news-release/2024/03/14/2846730/0/en/TFF-Pharmaceuticals-to-Participate-in-the-36th-Annual-Roth-Conference-March-17-19-2024.html

    GLOBENEWSWIRE
    14 Mar 2024
    Share Share
    TFF Pharma to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder
    TFF Pharma to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder

    https://www.globenewswire.com//news-release/2024/01/24/2815211/0/en/TFF-Pharmaceuticals-to-Present-Data-from-Phase-2-Trial-of-Voriconazole-Inhalation-Powder-TFF-VORI-for-the-Treatment-of-Invasive-Pulmonary-Aspergillosis-at-the-11th-Advances-Against.html

    GLOBENEWSWIRE
    24 Jan 2024
    Share Share
    TFF Pharma Announces Acceptance of Late-Breaking Abstract for Presentation
    TFF Pharma Announces Acceptance of Late-Breaking Abstract for Presentation

    https://www.globenewswire.com//news-release/2024/01/09/2806242/0/en/TFF-Pharmaceuticals-Announces-Acceptance-of-Late-Breaking-Abstract-for-Presentation-at-the-44th-Annual-International-Society-for-Heart-and-Lung-Transplantation-ISHLT-2024-Meeting.html

    GLOBENEWSWIRE
    09 Jan 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search